BioCon Limited
20th KM Hosur Road
Electronics City
Bangalore
560 100
Tel: 90-80-2808-2808
Fax: 91-80-2852-3423
Website: http://biocon.com/
Email: contact.us@biocon.com
69 articles about BioCon Limited
-
Mylan Inc. Announces Strategic Collaboration with BioCon Limited to Enter the Global Generic Biologics Market
6/29/2009
-
BioCon Limited Presents Human Clinical Data on IN-105 (Oral Insulin) at the EASD Meeting in Rome
9/8/2008
-
BioCon Limited and Abraxis BioScience, Inc. Launch ABRAXANE in India for Treatment of Breast Cancer
7/18/2008
-
India's BioCon Limited to Buy U.S. Firm for $400M
4/14/2008
-
BioCon Buys 70% Stake in German Company, AxiCorp for 30M Euro
2/15/2008
-
Abraxis BioScience, Inc. and BioCon Limited Announce Approval of ABRAXANE in India for the Treatment of Breast Cancer
10/18/2007
-
Abraxis BioScience, Inc. Announces Licensing Agreement with BioCon Limited for the Commercialization of ABRAXANE in India
8/9/2007
-
Abraxis BioScience, Inc. and BioCon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
7/20/2007
-
Bentley Pharmaceuticals Signs A Licensing Agreement With Biocon Limited To Develop And Market Bentley's Intranasal Insulin Spray In 85 Countries
11/15/2005